Overall survival with abiraterone acetate plus prednisone vs. docetaxel for the treatment of metastatic hormone-sensitive prostate cancer: An updated network meta-analysis
Feyerabend, S., Saad, F., Ito, T., Diels, J., Van Sanden, S., De Porre, P., Roiz, J., Abogunrin, S., Koufopoulou, M., Fizazi, K.Volume:
18
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(19)31009-7
Date:
March, 2019
File:
PDF, 90 KB
2019